Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
254.5 ILa | 0.00% | +0.51% | -24.46% |
Valuation
Fiscal Period: December | 2021 | 2022 |
---|---|---|
Capitalization 1 | 24.89 | 26.2 |
Enterprise Value (EV) 1 | 7.24 | 11.96 |
P/E ratio | -3.85 x | -5.24 x |
Yield | - | - |
Capitalization / Revenue | - | 261,994,030 x |
EV / Revenue | - | 261,993,888 x |
EV / EBITDA | -4.21 x | -5.36 x |
EV / FCF | -12,597,917 x | -16,779,690 x |
FCF Yield | -0% | -0% |
Price to Book | 1.4 x | 1.93 x |
Nbr of stocks (in thousands) | 3,309 | 3,309 |
Reference price 2 | 7.520 | 7.917 |
Announcement Date | 3/24/22 | 3/23/23 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net sales | - | - | - | - | - | 0.1 |
EBITDA 1 | -1.228 | -2.499 | -2.058 | -2.024 | -5.913 | -4.884 |
EBIT 1 | -1.477 | -2.737 | -2.224 | -2.109 | -5.998 | -4.952 |
Operating Margin | - | - | - | - | - | -4,952% |
Earnings before Tax (EBT) 1 | -1.469 | -2.728 | -2.15 | -2.299 | -6.456 | -4.982 |
Net income 1 | -1.469 | -2.728 | -2.15 | -2.299 | -6.456 | -4.982 |
Net margin | - | - | - | - | - | -4,982% |
EPS 2 | -4.897 | -9.093 | -7.170 | -7.663 | -1.951 | -1.510 |
Free Cash Flow | - | - | -1.237 | -0.9885 | -1.975 | -1.561 |
FCF margin | - | - | - | - | - | -1,561.38% |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 11/5/20 | 11/5/20 | 11/5/20 | 3/27/21 | 3/24/22 | 3/23/23 |
Balance Sheet Analysis
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net Debt | - | - | - | - | - | - |
Net Cash position | - | 1.51 | 2.73 | 0.94 | 17.6 | 14.2 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow | - | - | -1.24 | -0.99 | -1.98 | -1.56 |
ROE (net income / shareholders' equity) | - | - | -86.1% | -103% | -68.3% | -31.8% |
ROA (Net income/ Total Assets) | - | - | -45.8% | -43.3% | -35.9% | -18.2% |
Assets 1 | - | - | 4.694 | 5.308 | 17.97 | 27.32 |
Book Value Per Share | - | 5.640 | 10.90 | 3.910 | 5.350 | 4.110 |
Cash Flow per Share | - | 5.020 | 9.480 | 3.560 | 5.380 | 1.900 |
Capex 1 | 0.03 | 0.01 | 0.01 | 0.04 | 0.17 | 0.09 |
Capex / Sales | - | - | - | - | - | 92% |
Announcement Date | 11/5/20 | 11/5/20 | 11/5/20 | 3/27/21 | 3/24/22 | 3/23/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
- Stock Market
- Equities
- PLNT Stock
- Financials PlantArc Bio Ltd.